Masimo

Company Snapshot

Founded: 1989
Entity Type: Public
Employees: 3,600
Region: U.S.
Revenue: $2,094.4 Millions
Revenue Year: 2024
Headquarter: California, U.S.
Key Geographics: U.S., Europe, Middle East and Africa, Asia, Australia, North America, South America
Corporate Address: 52 Discovery Irvine, California 92618 U.S. Tel. +1-949-297-7000 www.masimo.com

Company Overview

Masimo is a global medical technology company focused on developing, manufacturing, and marketing noninvasive monitoring technologies. The company focuses on improving lives and patient outcomes and reducing healthcare costs by expanding noninvasive monitoring to new applications and locations. The company conducts business through two business segments: healthcare and non-healthcare.

The company caters to the OTC drugs, devices, and diagnostics market through the healthcare segment. The healthcare business develops, manufactures, and markets noninvasive patient monitoring technologies, hospital automation solutions, remote monitoring devices, and consumer health products. These products typically include a monitor or circuit board, proprietary sensors (single-use or reusable), software, cables, and related services.

The company has a presence in over 150 countries, with a strong presence in the U.S., Europe, the Middle East and Africa, Asia and Australia, and North and South America.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Masimo In Reports

OTC Drugs, Medical Devices and Diagnostics: Global Markets

BCC Research Market Analyst says global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029

Wearable Medical Devices: Technologies and Global Markets

BCC Research Market Analyst says global market for wearable medical devices was valued at $35.6 billion in 2023 & estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029.

Epilepsy Monitoring Devices: Global Market Outlook

BCC Research Market Report aims to provide a comprehensive study of the global market for epilepsy monitoring devices.

Company's Business Segments

  • Healthcare : The healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software, cables and other services.
  • Non-healthcare : Non-healthcare business develops, manufactures, markets, and sells home sound integration technologies and accessories, along with licensing complete high-performance in-vehicle audio systems under iconic consumer brands such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.

Applications/End User Industries

  • Hospitals
  • Emergency Medical Service (EMS) Providers
  • Home Care Providers
  • Physician Offices
  • Long-Term Care Facilities
  • Consumers
  • Automotive